Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.
- Published In:
- Molecular brain, 18(1), 54 (2025)
- Authors:
- Mouhammad, Zaynab A, Rombaut, Anne, Bermúdez, Mariana Yolotzin García, Vohra, Rupali, Tribble, James R, Williams, Pete A, Kolko, Miriam
- Database ID:
- RPEP-12653
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12653APA
Mouhammad, Zaynab A; Rombaut, Anne; Bermúdez, Mariana Yolotzin García; Vohra, Rupali; Tribble, James R; Williams, Pete A; Kolko, Miriam. (2025). Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.. Molecular brain, 18(1), 54. https://doi.org/10.1186/s13041-025-01224-8
MLA
Mouhammad, Zaynab A, et al. "Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.." Molecular brain, 2025. https://doi.org/10.1186/s13041-025-01224-8
RethinkPeptides
RethinkPeptides Research Database. "Systemic semaglutide provides a mild vasoprotective and anti..." RPEP-12653. Retrieved from https://rethinkpeptides.com/research/mouhammad-2025-systemic-semaglutide-provides-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.